Verônica Silva Vilela, Bruno Rangel Antunes da Silva, Cláudia Henrique da Costa, Agnaldo José Lopes, Roger Abramino Levy, Rogério Rufino. BMC Res Notes 2018
Times Cited: 6
Times Cited: 6
Times Cited
Times Co-cited
Similarity
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study.
Muriel Elhai, Marouane Boubaya, Oliver Distler, Vanessa Smith, Marco Matucci-Cerinic, Juan José Alegre Sancho, Marie-Elise Truchetet, Yolanda Braun-Moscovici, Florenzo Iannone, Pavel I Novikov,[...]. Ann Rheum Dis 2019
Muriel Elhai, Marouane Boubaya, Oliver Distler, Vanessa Smith, Marco Matucci-Cerinic, Juan José Alegre Sancho, Marie-Elise Truchetet, Yolanda Braun-Moscovici, Florenzo Iannone, Pavel I Novikov,[...]. Ann Rheum Dis 2019
50
Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis.
Christopher P Denton, Voon H Ong, Shiwen Xu, Haiyin Chen-Harris, Zora Modrusan, Robert Lafyatis, Dinesh Khanna, Angelika Jahreis, Jeffrey Siegel, Thierry Sornasse. Ann Rheum Dis 2018
Christopher P Denton, Voon H Ong, Shiwen Xu, Haiyin Chen-Harris, Zora Modrusan, Robert Lafyatis, Dinesh Khanna, Angelika Jahreis, Jeffrey Siegel, Thierry Sornasse. Ann Rheum Dis 2018
50
A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease.
Dimitrios Daoussis, Konstantinos Melissaropoulos, Georgios Sakellaropoulos, Ioannis Antonopoulos, Theodora E Markatseli, Theodora Simopoulou, Panagiotis Georgiou, Andrew P Andonopoulos, Alexandros A Drosos, Lazaros Sakkas,[...]. Semin Arthritis Rheum 2017
Dimitrios Daoussis, Konstantinos Melissaropoulos, Georgios Sakellaropoulos, Ioannis Antonopoulos, Theodora E Markatseli, Theodora Simopoulou, Panagiotis Georgiou, Andrew P Andonopoulos, Alexandros A Drosos, Lazaros Sakkas,[...]. Semin Arthritis Rheum 2017
33
Expression of the costimulatory molecule BB-1 and its receptors in patients with scleroderma-polymyositis overlap syndrome.
Ken-ya Murata, Kazuma Sugie, Miwa Takamure, Satoshi Ueno. J Neurol Sci 2002
Ken-ya Murata, Kazuma Sugie, Miwa Takamure, Satoshi Ueno. J Neurol Sci 2002
40
Efficacy and safety of rituximab in systemic sclerosis: French retrospective study and literature review.
Mathilde Thiebaut, David Launay, Sébastien Rivière, Thibault Mahévas, Syrine Bellakhal, Eric Hachulla, Olivier Fain, Arsène Mekinian. Autoimmun Rev 2018
Mathilde Thiebaut, David Launay, Sébastien Rivière, Thibault Mahévas, Syrine Bellakhal, Eric Hachulla, Olivier Fain, Arsène Mekinian. Autoimmun Rev 2018
33
Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.
Dinesh Khanna, Cathie Spino, Sindhu Johnson, Lorinda Chung, Michael L Whitfield, Christopher P Denton, Veronica Berrocal, Jennifer Franks, Bhavan Mehta, Jerry Molitor,[...]. Arthritis Rheumatol 2020
Dinesh Khanna, Cathie Spino, Sindhu Johnson, Lorinda Chung, Michael L Whitfield, Christopher P Denton, Veronica Berrocal, Jennifer Franks, Bhavan Mehta, Jerry Molitor,[...]. Arthritis Rheumatol 2020
33
Effect of long-term treatment with rituximab on pulmonary function and skin fibrosis in patients with diffuse systemic sclerosis.
Dimitrios Daoussis, Stamatis-Nick C Liossis, Athanassios C Tsamandas, Christina Kalogeropoulou, Fotini Paliogianni, Chaido Sirinian, Georgios Yiannopoulos, Andrew P Andonopoulos. Clin Exp Rheumatol 2012
Dimitrios Daoussis, Stamatis-Nick C Liossis, Athanassios C Tsamandas, Christina Kalogeropoulou, Fotini Paliogianni, Chaido Sirinian, Georgios Yiannopoulos, Andrew P Andonopoulos. Clin Exp Rheumatol 2012
33
Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab.
D McGonagle, A L Tan, J Madden, A C Rawstron, A Rehman, P Emery, S Thomas. Rheumatology (Oxford) 2008
D McGonagle, A L Tan, J Madden, A C Rawstron, A Rehman, P Emery, S Thomas. Rheumatology (Oxford) 2008
33
Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial.
Geetabali Sircar, Rudra Prosad Goswami, Dipankar Sircar, Alakendu Ghosh, Parasar Ghosh. Rheumatology (Oxford) 2018
Geetabali Sircar, Rudra Prosad Goswami, Dipankar Sircar, Alakendu Ghosh, Parasar Ghosh. Rheumatology (Oxford) 2018
33
Outcomes of patients with systemic sclerosis treated with tocilizumab: Case series and review of the literature.
Galia Zacay, Yair Levy. Best Pract Res Clin Rheumatol 2018
Galia Zacay, Yair Levy. Best Pract Res Clin Rheumatol 2018
33
B cell depletion treatment decreases CD4+IL4+ and CD4+CD40L+ T cells in patients with systemic sclerosis.
Ioannis Antonopoulos, Dimitrios Daoussis, Maria-Eleni Lalioti, Theodora E Markatseli, Alexandros A Drosos, Stavros Taraviras, Andrew P Andonopoulos, Stamatis-Nick C Liossis. Rheumatol Int 2019
Ioannis Antonopoulos, Dimitrios Daoussis, Maria-Eleni Lalioti, Theodora E Markatseli, Alexandros A Drosos, Stavros Taraviras, Andrew P Andonopoulos, Stamatis-Nick C Liossis. Rheumatol Int 2019
33
B cell infiltration in systemic sclerosis-associated interstitial lung disease.
Robert Lafyatis, Carl O'Hara, Carol A Feghali-Bostwick, Eric Matteson. Arthritis Rheum 2007
Robert Lafyatis, Carl O'Hara, Carol A Feghali-Bostwick, Eric Matteson. Arthritis Rheum 2007
33
Abatacept induces clinical improvement in patients with severe systemic sclerosis.
F V de Paoli, B D Nielsen, F Rasmussen, B Deleuran, K Søndergaard. Scand J Rheumatol 2014
F V de Paoli, B D Nielsen, F Rasmussen, B Deleuran, K Søndergaard. Scand J Rheumatol 2014
33
Critical contribution of the interleukin-6/signal transducer and activator of transcription 3 axis to vasculopathy associated with systemic sclerosis.
Takashi Taniguchi, Yoshihide Asano, Takemichi Fukasawa, Ayumi Yoshizaki, Shinichi Sato. J Dermatol 2017
Takashi Taniguchi, Yoshihide Asano, Takemichi Fukasawa, Ayumi Yoshizaki, Shinichi Sato. J Dermatol 2017
33
Rituximab treatment in patients with systemic sclerosis and interstitial lung disease.
Abdel Gaffar A Mohammed, Ammar Alshihre, Ibrahim Abdulrazag Al-Homood. Ann Thorac Med 2017
Abdel Gaffar A Mohammed, Ammar Alshihre, Ibrahim Abdulrazag Al-Homood. Ann Thorac Med 2017
33
Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study.
Dimitrios Daoussis, Stamatis-Nick C Liossis, Athanassios C Tsamandas, Christina Kalogeropoulou, Alexandra Kazantzi, Chaido Sirinian, Maria Karampetsou, Georgios Yiannopoulos, Andrew P Andonopoulos. Rheumatology (Oxford) 2010
Dimitrios Daoussis, Stamatis-Nick C Liossis, Athanassios C Tsamandas, Christina Kalogeropoulou, Alexandra Kazantzi, Chaido Sirinian, Maria Karampetsou, Georgios Yiannopoulos, Andrew P Andonopoulos. Rheumatology (Oxford) 2010
33
Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis.
Eliza F Chakravarty, Viktor Martyanov, David Fiorentino, Tammara A Wood, David James Haddon, Justin Ansel Jarrell, Paul J Utz, Mark C Genovese, Michael L Whitfield, Lorinda Chung. Arthritis Res Ther 2015
Eliza F Chakravarty, Viktor Martyanov, David Fiorentino, Tammara A Wood, David James Haddon, Justin Ansel Jarrell, Paul J Utz, Mark C Genovese, Michael L Whitfield, Lorinda Chung. Arthritis Res Ther 2015
33
Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis.
Matthieu Ponsoye, Camelia Frantz, Nadira Ruzehaji, Carole Nicco, Muriel Elhai, Barbara Ruiz, Anne Cauvet, Sonia Pezet, Marie Laure Brandely, Frédéric Batteux,[...]. Ann Rheum Dis 2016
Matthieu Ponsoye, Camelia Frantz, Nadira Ruzehaji, Carole Nicco, Muriel Elhai, Barbara Ruiz, Anne Cauvet, Sonia Pezet, Marie Laure Brandely, Frédéric Batteux,[...]. Ann Rheum Dis 2016
33
B cell depletion therapy upregulates Dkk-1 skin expression in patients with systemic sclerosis: association with enhanced resolution of skin fibrosis.
Dimitrios Daoussis, Athanassios Tsamandas, Ioannis Antonopoulos, Alexandra Filippopoulou, Dionysios J Papachristou, Nicholaos I Papachristou, Andrew P Andonopoulos, Stamatis-Nick Liossis. Arthritis Res Ther 2016
Dimitrios Daoussis, Athanassios Tsamandas, Ioannis Antonopoulos, Alexandra Filippopoulou, Dionysios J Papachristou, Nicholaos I Papachristou, Andrew P Andonopoulos, Stamatis-Nick Liossis. Arthritis Res Ther 2016
33
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group.
Suzana Jordan, Jörg H W Distler, Britta Maurer, Dörte Huscher, Jacob M van Laar, Yannick Allanore, Oliver Distler. Ann Rheum Dis 2015
Suzana Jordan, Jörg H W Distler, Britta Maurer, Dörte Huscher, Jacob M van Laar, Yannick Allanore, Oliver Distler. Ann Rheum Dis 2015
33
Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay.
Maurizio Cutolo, Stefano Soldano, Paola Montagna, Amelia Chiara Trombetta, Paola Contini, Barbara Ruaro, Alberto Sulli, Stefano Scabini, Emanuela Stratta, Sabrina Paolino,[...]. Arthritis Res Ther 2018
Maurizio Cutolo, Stefano Soldano, Paola Montagna, Amelia Chiara Trombetta, Paola Contini, Barbara Ruaro, Alberto Sulli, Stefano Scabini, Emanuela Stratta, Sabrina Paolino,[...]. Arthritis Res Ther 2018
33
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial.
Dinesh Khanna, Christopher P Denton, Angelika Jahreis, Jacob M van Laar, Tracy M Frech, Marina E Anderson, Murray Baron, Lorinda Chung, Gerhard Fierlbeck, Santhanam Lakshminarayanan,[...]. Lancet 2016
Dinesh Khanna, Christopher P Denton, Angelika Jahreis, Jacob M van Laar, Tracy M Frech, Marina E Anderson, Murray Baron, Lorinda Chung, Gerhard Fierlbeck, Santhanam Lakshminarayanan,[...]. Lancet 2016
33
Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial.
Jessica K Gordon, Viktor Martyanov, Jennifer M Franks, Elana J Bernstein, Jackie Szymonifka, Cynthia Magro, Horatio F Wildman, Tammara A Wood, Michael L Whitfield, Robert F Spiera. Arthritis Rheumatol 2018
Jessica K Gordon, Viktor Martyanov, Jennifer M Franks, Elana J Bernstein, Jackie Szymonifka, Cynthia Magro, Horatio F Wildman, Tammara A Wood, Michael L Whitfield, Robert F Spiera. Arthritis Rheumatol 2018
33
B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skin.
Dimitrios Daoussis, Athanassios C Tsamandas, Stamatis-Nick C Liossis, Ioannis Antonopoulos, Elli Karatza, Georgios Yiannopoulos, Andrew P Andonopoulos. Arthritis Res Ther 2012
Dimitrios Daoussis, Athanassios C Tsamandas, Stamatis-Nick C Liossis, Ioannis Antonopoulos, Elli Karatza, Georgios Yiannopoulos, Andrew P Andonopoulos. Arthritis Res Ther 2012
33
Systemic sclerosis: a prototypic multisystem fibrotic disorder.
John Varga, David Abraham. J Clin Invest 2007
John Varga, David Abraham. J Clin Invest 2007
33
Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells.
Shinichi Sato, Manabu Fujimoto, Minoru Hasegawa, Kazukiko Takehara. Arthritis Rheum 2004
Shinichi Sato, Manabu Fujimoto, Minoru Hasegawa, Kazukiko Takehara. Arthritis Rheum 2004
33
Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis.
M Cutolo, A Sulli, C Pizzorni, S Accardo. J Rheumatol 2000
M Cutolo, A Sulli, C Pizzorni, S Accardo. J Rheumatol 2000
33
Effects of Longterm Treatment with Bosentan and Iloprost on Nailfold Absolute Capillary Number, Fingertip Blood Perfusion, and Clinical Status in Systemic Sclerosis.
Amelia Chiara Trombetta, Carmen Pizzorni, Barbara Ruaro, Sabrina Paolino, Alberto Sulli, Vanessa Smith, Maurizio Cutolo. J Rheumatol 2016
Amelia Chiara Trombetta, Carmen Pizzorni, Barbara Ruaro, Sabrina Paolino, Alberto Sulli, Vanessa Smith, Maurizio Cutolo. J Rheumatol 2016
33
Infliximab therapy in pulmonary fibrosis associated with collagen vascular disease.
K M Antoniou, M Mamoulaki, K Malagari, H D Kritikos, D Bouros, N M Siafakas, D T Boumpas. Clin Exp Rheumatol 2007
K M Antoniou, M Mamoulaki, K Malagari, H D Kritikos, D Bouros, N M Siafakas, D T Boumpas. Clin Exp Rheumatol 2007
16
A Case Report of Successful Treatment of Recalcitrant Childhood Localized Scleroderma with Infliximab and Leflunomide.
Ian D Ferguson, Peter Weiser, Kathryn S Torok. Open Rheumatol J 2015
Ian D Ferguson, Peter Weiser, Kathryn S Torok. Open Rheumatol J 2015
16
Treatment of systemic sclerosis with tocilizumab.
Marisa Fernandes das Neves, Susana Oliveira, Marta C Amaral, José Delgado Alves. Rheumatology (Oxford) 2015
Marisa Fernandes das Neves, Susana Oliveira, Marta C Amaral, José Delgado Alves. Rheumatology (Oxford) 2015
16
Two-year results of an open pilot study of a 2-treatment course with rituximab in patients with early systemic sclerosis with diffuse skin involvement.
Vanessa Smith, Yves Piette, Jens T van Praet, Saskia Decuman, Ellen Deschepper, Dirk Elewaut, Filip De Keyser. J Rheumatol 2013
Vanessa Smith, Yves Piette, Jens T van Praet, Saskia Decuman, Ellen Deschepper, Dirk Elewaut, Filip De Keyser. J Rheumatol 2013
16
B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial.
Silvia Bosello, Maria De Santis, Gina Lama, Cristina Spanò, Cristiana Angelucci, Barbara Tolusso, Gigliola Sica, Gianfranco Ferraccioli. Arthritis Res Ther 2010
Silvia Bosello, Maria De Santis, Gina Lama, Cristina Spanò, Cristiana Angelucci, Barbara Tolusso, Gigliola Sica, Gianfranco Ferraccioli. Arthritis Res Ther 2010
16
Rituximab-induced neutropenia in a patient with inflammatory myopathy and systemic sclerosis overlap disease.
Qasim Akram, Mark Roberts, Chester Oddis, Arianne Herrick, Hector Chinoy. Reumatologia 2016
Qasim Akram, Mark Roberts, Chester Oddis, Arianne Herrick, Hector Chinoy. Reumatologia 2016
50
Morphea in a patient undergoing treatment with ustekinumab.
Alexa B Steuer, Erik Peterson, Kristen Lo Sicco, Andrew G Franks. JAAD Case Rep 2019
Alexa B Steuer, Erik Peterson, Kristen Lo Sicco, Andrew G Franks. JAAD Case Rep 2019
50
Safety and tolerability of an anti-CD19 monoclonal antibody, MEDI-551, in subjects with systemic sclerosis: a phase I, randomized, placebo-controlled, escalating single-dose study.
Elena Schiopu, Soumya Chatterjee, Vivien Hsu, Armando Flor, Daniel Cimbora, Kaushik Patra, Wenliang Yao, Jing Li, Katie Streicher, Kathleen McKeever,[...]. Arthritis Res Ther 2016
Elena Schiopu, Soumya Chatterjee, Vivien Hsu, Armando Flor, Daniel Cimbora, Kaushik Patra, Wenliang Yao, Jing Li, Katie Streicher, Kathleen McKeever,[...]. Arthritis Res Ther 2016
16
Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study.
Muriel Elhai, Marine Meunier, Marco Matucci-Cerinic, Britta Maurer, Gabriela Riemekasten, Tifenn Leturcq, Raffaele Pellerito, Carlos Alberto Von Mühlen, Alessandra Vacca, Paolo Airo,[...]. Ann Rheum Dis 2013
Muriel Elhai, Marine Meunier, Marco Matucci-Cerinic, Britta Maurer, Gabriela Riemekasten, Tifenn Leturcq, Raffaele Pellerito, Carlos Alberto Von Mühlen, Alessandra Vacca, Paolo Airo,[...]. Ann Rheum Dis 2013
16
Morphea associated with the use of adalimumab: a case report and review of the literature.
Julio Ramírez, M Victoria Hernández, Javier Galve, Juan D Cañete, Raimon Sanmartí. Mod Rheumatol 2012
Julio Ramírez, M Victoria Hernández, Javier Galve, Juan D Cañete, Raimon Sanmartí. Mod Rheumatol 2012
16
Suppression of T Cell Activation and Collagen Accumulation by an Anti-IFNAR1 mAb, Anifrolumab, in Adult Patients with Systemic Sclerosis.
Xiang Guo, Brandon W Higgs, Anne C Bay-Jensen, Morten A Karsdal, Yihong Yao, Lorin K Roskos, Wendy I White. J Invest Dermatol 2015
Xiang Guo, Brandon W Higgs, Anne C Bay-Jensen, Morten A Karsdal, Yihong Yao, Lorin K Roskos, Wendy I White. J Invest Dermatol 2015
16
Proteasome blockade exerts an antifibrotic activity by coordinately down-regulating type I collagen and tissue inhibitor of metalloproteinase-1 and up-regulating metalloproteinase-1 production in human dermal fibroblasts.
Serena Fineschi, Walter Reith, Pierre André Guerne, Jean-Michel Dayer, Carlo Chizzolini. FASEB J 2006
Serena Fineschi, Walter Reith, Pierre André Guerne, Jean-Michel Dayer, Carlo Chizzolini. FASEB J 2006
16
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors.
Armen Yuri Gasparyan, Lilit Ayvazyan, Heather Blackmore, George D Kitas. Rheumatol Int 2011
Armen Yuri Gasparyan, Lilit Ayvazyan, Heather Blackmore, George D Kitas. Rheumatol Int 2011
16
Rituximab Experience in Patients With Long-standing Systemic Sclerosis-Associated Interstitial Lung Disease: A Series of 14 Patients.
Alper Sari, Denizcan Guven, Berkan Armagan, Abdulsamet Erden, Umut Kalyoncu, Omer Karadag, Sule Apras Bilgen, Ihsan Ertenli, Sedat Kiraz, Ali Akdogan. J Clin Rheumatol 2017
Alper Sari, Denizcan Guven, Berkan Armagan, Abdulsamet Erden, Umut Kalyoncu, Omer Karadag, Sule Apras Bilgen, Ihsan Ertenli, Sedat Kiraz, Ali Akdogan. J Clin Rheumatol 2017
16
Targeting interferons as a strategy for systemic sclerosis treatment.
Marzena Ciechomska, Urszula Skalska. Immunol Lett 2018
Marzena Ciechomska, Urszula Skalska. Immunol Lett 2018
16
Discordant response to rituximab in a systemic sclerosis patient with associated myositis.
Mario Fabri, Nicolas Hunzelmann, Thomas Krieg, Andrea Rubbert. J Am Acad Dermatol 2008
Mario Fabri, Nicolas Hunzelmann, Thomas Krieg, Andrea Rubbert. J Am Acad Dermatol 2008
16
Unprecedented success of rituximab therapy for prednisolone- and immunosuppressant-resistant systemic sclerosis-associated interstitial lung disease.
S Ebata, A Yoshizaki, T Fukasawa, K Nakamura, T Yamashita, S Miura, R Saigusa, Y Ichimura, T Takahashi, M Hirabayashi,[...]. Scand J Rheumatol 2017
S Ebata, A Yoshizaki, T Fukasawa, K Nakamura, T Yamashita, S Miura, R Saigusa, Y Ichimura, T Takahashi, M Hirabayashi,[...]. Scand J Rheumatol 2017
16
Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
D Sánchez-Cano, N Ortego-Centeno, J L Callejas, V Fonollosa Plá, R Ríos-Fernández, C Tolosa-Vilella, G Espinosa-Garriga, D Colunga-Argüelles, M V Egurbide-Arberas, M Rubio-Rivas,[...]. Rheumatol Int 2018
D Sánchez-Cano, N Ortego-Centeno, J L Callejas, V Fonollosa Plá, R Ríos-Fernández, C Tolosa-Vilella, G Espinosa-Garriga, D Colunga-Argüelles, M V Egurbide-Arberas, M Rubio-Rivas,[...]. Rheumatol Int 2018
16
The platelet-derived growth factor receptor/STAT3 signaling pathway regulates the phenotypic transition of corpus cavernosum smooth muscle in rats.
Jun-Feng Yan, Wen-Jie Huang, Jian-Feng Zhao, Hui-Ying Fu, Gao-Yue Zhang, Xiao-Jun Huang, Bo-Dong Lv. PLoS One 2017
Jun-Feng Yan, Wen-Jie Huang, Jian-Feng Zhao, Hui-Ying Fu, Gao-Yue Zhang, Xiao-Jun Huang, Bo-Dong Lv. PLoS One 2017
16
Treatment of psoriasis with ustekinumab improved skin tightening in systemic sclerosis.
Asako Ichihara, Masatoshi Jinnin, Hironobu Ihn. Clin Exp Rheumatol 2017
Asako Ichihara, Masatoshi Jinnin, Hironobu Ihn. Clin Exp Rheumatol 2017
16
Targeting very early systemic sclerosis: a case-based review.
Konstantinos Melissaropoulos, Pantelis Kraniotis, Dimitrios Bogdanos, Theodoros Dimitroulas, Lazaros Sakkas, Dimitrios Daoussis. Rheumatol Int 2019
Konstantinos Melissaropoulos, Pantelis Kraniotis, Dimitrios Bogdanos, Theodoros Dimitroulas, Lazaros Sakkas, Dimitrios Daoussis. Rheumatol Int 2019
16
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.